|
| Marker | Result | Description |
|
| CD3 (PS1) | T cells positive | Pan T cell, epsilon subunit of the CD3 T cell receptor complex |
| CD5 (4C7) | T cells positive | Pan T cell antigen, mature B cell subset, and thymic carcinoma |
| CD10 | Negative | Follicle center B cells, CALLA (B and T ALL) |
| CD20 | B cells positive | Pan B cell antigen (L26) |
| CD21 | Follicular dendritic cells positive | C3d and EBV receptor, mature B cells, and follicular dendritic cells |
| CD23 (MHM6) | B cells positive | Low affinity IgE receptor, mature B cells, and CLL/SLL |
| CD43 | T cells positive | T cells, B cell subset, myeloid cells, and histiocytes (Leu22) |
| CD68 | Histiocytes/macrophages positive | Macrophages and myeloid cells (KP1) |
| PAX-5 (BSAP) | B cells positive | B cell and Hodgkin’s lymphoma |
| BCL-1 | Negative | Mantle cell lymphoma (Cyclin D1, PRAD-1) |
| BCL-2 IHC | Lymphocytes positive | Antiapoptosis protein, follicular lymphoma, and B cell subset |
| BCL-6 | Negative | Follicle center B cells |
| MUM-1 | Plasma cells positive | Plasma cells postgerminal center B cells, activated T cells |
| Kappa (Px) | Polytypic in plasma cells | Kappa immunoglobulin light chain, B cells, and plasma cells |
| Lambda (Px) | Polytypic in plasma cells | Lambda immunoglobulin light chain, B cells, and plasma cells |
| Ki-67 (MIB-1) | 1–4% | Cell proliferation marker (MIB-1) |
|
